We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
-$179M
Cap. Flow
-$339M
Cap. Flow %
-11.66%
Top 10 Hldgs %
11.95%
Holding
1,370
New
136
Increased
551
Reduced
477
Closed
195

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$15.7M
2
PM icon
Philip Morris
PM
+$13.6M
3
MO icon
Altria Group
MO
+$13.4M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.7M
5
HUBB icon
Hubbell
HUBB
+$8.92M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$61.6M
2
V icon
Visa
V
+$20.6M
3
ADBE icon
Adobe
ADBE
+$13.8M
4
ACN icon
Accenture
ACN
+$12.5M
5
PCAR icon
PACCAR
PCAR
+$9.72M

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Healthcare 13.07%
3 Industrials 12.02%
4 Consumer Discretionary 10.67%
5 Financials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAS icon
1251
Hasbro
HAS
$12.6B
– –
-8,735
Closed -$469K
HII icon
1252
Huntington Ingalls Industries
HII
$11.3B
– –
-3,529
Closed -$731K
HLX icon
1253
Helix Energy Solutions
HLX
$1.46B
– –
-11,522
Closed -$89.2K
HRB icon
1254
H&R Block
HRB
$5.18B
– –
-16,746
Closed -$590K
IBRX icon
1255
ImmunityBio
IBRX
$7.44B
– –
-107,144
Closed -$195K
IDT icon
1256
IDT Corp
IDT
$1.6B
– –
-6,777
Closed -$231K
IGMS
1257
DELISTED
IGM Biosciences
IGMS
– –
-38,078
Closed -$523K
IMCR icon
1258
Immunocore
IMCR
$1.78B
– –
-12,624
Closed -$624K
IMTX icon
1259
Immatics
IMTX
$1.24B
– –
-75,841
Closed -$523K
INCY icon
1260
Incyte
INCY
$23.5B
– –
-18,090
Closed -$1.31M
IOVA icon
1261
Iovance Biotherapeutics
IOVA
$2.23B
– –
-112,238
Closed -$686K
IRM icon
1262
Iron Mountain
IRM
$38.2B
– –
-28,858
Closed -$1.53M
ITOS
1263
DELISTED
iTeos Therapeutics
ITOS
– –
-32,887
Closed -$448K
IVZ icon
1264
Invesco
IVZ
$13.3B
– –
-24,568
Closed -$403K
J icon
1265
Jacobs Solutions
J
$15.9B
– –
-15,122
Closed -$1.47M
JANX icon
1266
Janux Therapeutics
JANX
$935M
– –
-55,483
Closed -$671K
JD icon
1267
JD.com
JD
$40.8B
– –
-8,689
Closed -$381K
JKHY icon
1268
Jack Henry & Associates
JKHY
$10.7B
– –
-1,342
Closed -$202K
JMIA
1269
Jumia Technologies
JMIA
$726M
– –
-21,033
Closed -$69.2K
K
1270
DELISTED
Kellanova
K
– –
-25,916
Closed -$1.63M
KDP icon
1271
Keurig Dr Pepper
KDP
$40.4B
– –
-54,746
Closed -$1.93M
KSA icon
1272
iShares MSCI Saudi Arabia ETF
KSA
$647M
– –
-5,665
Closed -$219K
KSS icon
1273
Kohl's
KSS
$2.03B
– –
-10,554
Closed -$248K
KTB icon
1274
Kontoor Brands
KTB
$4.62B
– –
-5,063
Closed -$245K
L icon
1275
Loews
L
$24.3B
– –
-16,298
Closed -$946K
49 50
51
52 53

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2023 Portfolio in Review

As of Q2 2023, Vident Investment Advisory held 1,370 positions worth $2.9B, down 5.8% from $3.08B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Vident Investment Advisory withdrew a net $339M in Q2 2023, closing 195 positions and reducing 477 holdings. Its most notable exit was Polaris, an estimated $8.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Hubbell worth $10.7M.

  • Vident Investment Advisory's largest Q2 2023 buy was Hubbell: 32,210 shares worth $10.7M.
  • Vident Investment Advisory added most to T-Mobile US in Q2 2023, an estimated $15.7M increase.
  • Vident Investment Advisory's biggest Q2 2023 reduction was Apple, cutting an estimated $61.6M.
  • Vident Investment Advisory fully exited Polaris in Q2 2023, selling an estimated $8.05M.
  • Vident Investment Advisory's ten largest holdings make up 12% of its $2.9B portfolio in Q2 2023.
  • Vident Investment Advisory opened 136 new positions and closed 195 in Q2 2023.
  • Vident Investment Advisory's portfolio value fell 5.8% quarter-over-quarter to $2.9B.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.